{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:42:02Z","timestamp":1790775722418,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T00:00:00Z","timestamp":1578960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s40520-019-01458-2","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T16:14:32Z","timestamp":1579018472000},"page":"265-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A meta-analysis on the levels of VILIP-1 in the CSF of Alzheimer\u2019s disease compared to normal controls and other neurodegenerative conditions"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9844-4010","authenticated-orcid":false,"given":"Ioannis A.","family":"Mavroudis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Foivos","family":"Petridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Symela","family":"Chatzikonstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Karantali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Kazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"1458_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/1533317515602548","volume":"31","author":"SJ Baloyannis","year":"2016","unstructured":"Baloyannis SJ, Mavroudis I, Baloyannis IS et al (2016) Mammillary bodies in Alzheimer's disease: a golgi and electron microscope study. Am J Alzheimers Dis Other Dement 31:247\u2013256","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"1458_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer\u2019s disease. Lancet 368:387\u2013403","journal-title":"Lancet"},{"key":"1458_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/msj.20157","volume":"77","author":"DP Perl","year":"2010","unstructured":"Perl DP (2010) Neuropathology of Alzheimer\u2019s disease. Mt Sinai J Med 77:32\u201342","journal-title":"Mt Sinai J Med"},{"key":"1458_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/1533317510382892","volume":"25","author":"IA Mavroudis","year":"2010","unstructured":"Mavroudis IA, Fotiou DF, Adipepe LF et al (2010) Morphological changes of the human purkinje cells and deposition of neuritic plaques and neurofibrillary tangles on the cerebellar cortex of Alzheimer's disease. Am J Alzheimers Dis Other Dement 25:585\u2013591","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"1458_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack Jr","year":"2016","unstructured":"Jack CR Jr, Bennett DA, Blennow K et al (2016) A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87:539\u2013547","journal-title":"Neurology"},{"key":"1458_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s13167-017-0110-x","volume":"8","author":"I Gozes","year":"2017","unstructured":"Gozes I (2017) Specific protein biomarker patterns for Alzheimer\u2019s disease: improved diagnostics in progress. EPMA J 8:255\u2013259","journal-title":"EPMA J"},{"key":"1458_CR7","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3233\/JAD-141050","volume":"43","author":"B Mroczko","year":"2015","unstructured":"Mroczko B, Groblewska M, Zboch M et al (2015) Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer\u2019s disease. J Alzheimers Dis 43:1031\u20131037","journal-title":"J Alzheimers Dis"},{"key":"1458_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/nn1117","volume":"6","author":"T Sippy","year":"2003","unstructured":"Sippy T, Cruz-Martin A, Jeromin A et al (2003) Acute changes in short-term plasticity at synapses with elevated levels of neuronal calcium sensor-1. Nat Neurosci 6:1031\u20131038","journal-title":"Nat Neurosci"},{"key":"1458_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000051244","volume":"12","author":"K Braunewell","year":"2001","unstructured":"Braunewell K, Riederer P, Spilker C et al (2001) Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patients. Dement Geriatr Cogn Disord 12:110\u2013116","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"5","key":"1458_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"20","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 20:13","journal-title":"BMC Med Res Methodol"},{"key":"1458_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3102\/1076998616674315","volume":"42","author":"JR Polanin","year":"2017","unstructured":"Polanin JR, Hennessy EA, Tanner-Smith EE (2017) A review of meta-analysis packages in R. J Educ Behav Stat 42:206\u2013242","journal-title":"J Educ Behav Stat"},{"key":"1458_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-018-0127-7","volume":"7","author":"H Zhang","year":"2018","unstructured":"Zhang H, Ng KP, Therriault J et al (2018) Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease. Transl Neurodegener 7:23","journal-title":"Transl Neurodegener"},{"key":"1458_CR13","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3233\/JAD-150705","volume":"50","author":"M Babi\u0107 Leko","year":"2016","unstructured":"Babi\u0107 Leko M, Borove\u010dki F, Dejanovi\u0107 N et al (2016) Predictive value of cerebrospinal fluid visinin-like protein-1 levels for Alzheimer's disease early detection and differential diagnosis in patients with mild cognitive impairment. J Alzheimers Dis 50:765\u2013778","journal-title":"J Alzheimers Dis"},{"key":"1458_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13195-015-0142-1","volume":"7","author":"MI Kester","year":"2015","unstructured":"Kester MI, Teunissen CE, Sutphen C et al (2015) Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort. Alzheimers Res Ther 7:59","journal-title":"Alzheimers Res Ther"},{"key":"1458_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/jnc.12331","volume":"127","author":"X Luo","year":"2013","unstructured":"Luo X, Hou L, Shi H et al (2013) CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies. J Neurochem 127:681\u2013690","journal-title":"J Neurochem"},{"key":"1458_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1212\/WNL.0b013e318248e568","volume":"78","author":"R Tarawneh","year":"2012","unstructured":"Tarawneh R, Lee JM, Ladenson JH et al (2012) CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease. Neurology 78:709\u2013719","journal-title":"Neurology"},{"key":"1458_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ana.22448","volume":"70","author":"R Tarawneh","year":"2011","unstructured":"Tarawneh R, D'Angelo G, Macy E et al (2011) Visinin-like protein-1: diagnostic and prognostic biomarker in Alzheimer disease. Ann Neurol 70:274\u2013285","journal-title":"Ann Neurol"},{"key":"1458_CR18","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3233\/JAD-170220","volume":"59","author":"P Muszy\u0144ski","year":"2017","unstructured":"Muszy\u0144ski P, Kulczy\u0144ska-Przybik A, Borawska R et al (2017) The relationship between markers of inflammation and degeneration in the central nervous system and the blood\u2013brain barrier impairment in Alzheimer's disease. J Alzheimers Dis 59:903\u2013912","journal-title":"J Alzheimers Dis"},{"key":"1458_CR19","doi-asserted-by":"publisher","first-page":"e01128","DOI":"10.1002\/brb3.1128","volume":"8","author":"M Babi\u0107 Leko","year":"2018","unstructured":"Babi\u0107 Leko M, Willumsen N, Nikolac Perkovi\u0107 M et al (2018) Association of MAPT haplotype-tagging polymorphisms with cerebrospinal fluid biomarkers of Alzheimer's disease: a preliminary study in a croatian cohort. Brain Behav 8:e01128","journal-title":"Brain Behav"},{"key":"1458_CR20","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3233\/JAD-141050","volume":"43","author":"B Mroczko","year":"2015","unstructured":"Mroczko B, Groblewska M, Zboch M et al (2015) Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer's disease. J Alzheimers Dis 43:1031\u20131037","journal-title":"J Alzheimers Dis"},{"key":"1458_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1042\/BJ20051001","volume":"391","author":"DW O\u2019Callaghan","year":"2005","unstructured":"O\u2019Callaghan DW, Haynes LP, Burgoyne RD (2005) High affinity interaction of the N-terminal myristoylation motif of the neuronal calcium sensor protein hippocalcin with phosphatidyl inositol 4,5-bisphosphate. Biochem J 391:231\u2013238","journal-title":"Biochem J"},{"key":"1458_CR22","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1071\/CH09355","volume":"63","author":"KH Braunewell","year":"2010","unstructured":"Braunewell KH, Paul B, Altarche-Xifro W et al (2010) Interactions of visinin-like proteins with phosphoinositides. Aust J Chem 63:350\u2013356","journal-title":"Aust J Chem"},{"key":"1458_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.neuron.2005.06.033","volume":"47","author":"F Coussen","year":"2005","unstructured":"Coussen F, Perrais D, Jaskolski F et al (2005) Coassembly of two GluR6 kainate receptor splice variants within a functional protein complex. Neuron 47:555\u2013566","journal-title":"Neuron"},{"key":"1458_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","volume":"74","author":"C Gotti","year":"2004","unstructured":"Gotti C, Clementi F (2004) Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74:363\u2013396","journal-title":"Prog Neurobiol"},{"key":"1458_CR25","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1006\/nbdi.2001.0432","volume":"8","author":"I Schnurra","year":"2001","unstructured":"Schnurra I, Bernstein HG, Riederer P et al (2001) The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer\u2019s disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer\u2019s disease? Neurobiol Dis 8:900\u2013909","journal-title":"Neurobiol Dis"},{"key":"1458_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1113\/jphysiol.1993.sp019950","volume":"472","author":"PS Chard","year":"1993","unstructured":"Chard PS, Bleakman D, Christakos S et al (1993) Calcium buffering properties of calbindin D28k and parvalbumin in rat sensory neurones. J Physiol 472:341\u2013357","journal-title":"J Physiol"},{"key":"1458_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2012.00020","volume":"5","author":"KH Braunewell","year":"2012","unstructured":"Braunewell KH (2012) The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer\u2019s disease-old wine in new bottle. Front Mol Neurosci 5:1\u201312","journal-title":"Front Mol Neurosci"},{"key":"1458_CR28","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1373\/clinchem.2008.104497","volume":"54","author":"JM Lee","year":"2008","unstructured":"Lee JM, Blennow K, Andreasen N et al (2008) The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients. Clin Chem 54:1617\u20131623","journal-title":"Clin Chem"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-019-01458-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40520-019-01458-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-019-01458-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T13:09:39Z","timestamp":1614431379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40520-019-01458-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,14]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1458"],"URL":"https:\/\/doi.org\/10.1007\/s40520-019-01458-2","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,14]]},"assertion":[{"value":"31 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study is a meta-analysis of previous studies and therefore no ethical approval needed. All the studies included had taken ethical approval","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The present study were carried out with full respect to human rights.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal right"}},{"value":"We confirm that the present study is based on the analysis of other studies which had obtained informed consent for all individuals.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}